Contacts
H. Lundbeck A/S
Sitemap
Home
About Lundbeck Research
Employment
Our Corporate Parent
Country web sites
Argentina
Australia
Austria
Belgium
Czech Republic
Chile
Denmark
Finland
Germany
Greece
Gulf countries
India
Ireland
Italy
Japan
Korea
Latvia
Lundbeck Research - USA
Mexico
Netherlands
Norway
Pakistan
Poland
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
United States of America
Quick access to
Our products
Select
Cipralex
Ebixa
Azilect
Serdolect
Circadin
Our therapy areas
Select
Depression
Anxiety
Alzheimer's disease
Parkinson's disease
Schizophrenia
Insomnia
Other Lundbeck sites
Select
CNSForum
Cipralex.com
Ebixa.com
Azilect.com
Serdolect.com
DepNet.com
DementiaNet
Brainexplorer
Patient Support Programme (iCan)
Psychotropics online
Sleep problems
My PD info
What are you looking for?
Annual report 2009
Order printed material
Employee profiles
Patient information
Pipeline
Partnering with us
Lundbeck A/S (LUN)
99.55 DKK -0.85
at 16:59:33
OMX Copenhagen 20 (OMXC20)
377.87 -0.49
at 16:59:33
Latest releases
Desmoteplase enters clinical phase II in Japan in ischaemic stroke representing Lundbeck's first clinical programme in Japan
16-Mar-2010
Fourth quarter and full year report 2009 - Lundbeck delivers 22 percent revenue growth for 2009 and meets financial expectations for 2009
04-Mar-2010
View all releases
Lundbeck Research USA, Inc.
215 College Road
Paramus, New Jersey 07652-1431
USA
Tel + 1 201 261 1331
Fax + 1 201 261 0623
Lu-usa1_webrequest@lundbeck.com
Contact
The specialist in psychiatry and pioneer in neurology
Disclaimer, Privacy Statement & Terms of Use